Funding Atlas programme

Therapeutic Catalyst

Cancer Research UK

JurisdictionUnited KingdomFunding typeGrant

Documented facts

Key facts

Funder: Cancer Research UK
Jurisdiction: United Kingdom
Record type: Opportunity
Funding type: Grant
Amount: GBP 350,000
Next deadline: 5 February 2027

Published rule provenance

Eligibility information

Country / jurisdiction: Rule not encoded
Organisation type: Rule not encoded
Company size: Rule not encoded
Stage: Encoded condition recorded; read its source quotation.
Eligibility rule, quoted from the funder
We invite applications for early drug discovery proposals from across all adult cancer indications and all types of antibody or small molecule formats.
Quoted source
Therapeutic area: Rule not encoded
Amount sought: Rule not encoded

Further quoted conditions

Eligibility rule, quoted from the funder: entity

You can apply for any of our Therapeutic Catalyst awards if you are an academic researcher based at any university or research institute world-wide.

Quoted source

Eligibility rule, quoted from the funder: area

We invite applications for early drug discovery proposals from across all adult cancer indications and all types of antibody or small molecule formats.

Quoted source

Eligibility rule, quoted from the funder: amount_requested

This award can provide funding of up to £350K for 18 - 24 months.

Quoted source

Site note: This record is not advice or a funder decision.